Journal article

APOBEC3G Genetic Variants and Their Influence on the Progression to AIDS

  • An, Ping Basic Research Program, SAIC Frederick, National Cancer Institute-Frederick Cancer Research and Development Center
  • Bleiber, Gabriela Institute of Microbiology, University of Lausanne, Lausanne
  • Duggal, Priya Inherited Disease Research Branch, National Human Genome Research Institute
  • Nelson, George Basic Research Program, SAIC Frederick, National Cancer Institute-Frederick Cancer Research and Development Center
  • May, Margaret Department of Social Medicine, University of Bristol, Bristol, United Kingdom
  • Mangeat, Bastien Department of Genetics and Microbiology, University of Geneva
  • Alobwede, Irene Division of Infectious Diseases, University Hospital of Geneva, Geneva, Switzerland
  • Trono, Didier Department of Genetics and Microbiology, University of Geneva
  • Vlahov, David Johns Hopkins University Bloomberg School of Public Health, Baltimore
  • Donfield, Sharyne Rho Inc., Chapel Hill, North Carolina
  • Goedert, James J. Viral Epidemiology Branch, National Cancer Institute, Bethesda, Maryland
  • Phair, John Fineberg School of Medicine, Northwestern University, Comprehensive AIDS Center, Chicago, Illinois
  • Buchbinder, Susan San Francisco Department of Public Health, San Francisco, California
  • O'Brien, Stephen J. Laboratory of Genomic Diversity, National Cancer Institute, Frederick
  • Telenti, Amalio Institute of Microbiology, University of Lausanne, Lausanne
  • Winkler, Cheryl A. Basic Research Program, SAIC Frederick, National Cancer Institute-Frederick Cancer Research and Development Center
Show more…
Published in:
  • Journal of Virology. - American Society for Microbiology. - 2004, vol. 78, no. 20, p. 11070-11076
English ABSTRACT
The cytosine deaminase APOBEC3G, in the absence of the human immunodeficiency virus type 1 (HIV-1) accessory gene HIV-1 viral infectivity factor (vif), inhibits viral replication by introducing G→A hypermutation in the newly synthesized HIV-1 DNA negative strand. We tested the hypothesis that genetic variants of APOBEC3G may modify HIV-1 transmission and disease progression. Single nucleotide polymorphisms were identified in the promoter region (three), introns (two), and exons (two). Genotypes were determined for 3,073 study participants enrolled in six HIV-AIDS prospective cohorts. One codon-changing variant, H186R in exon 4, was polymorphic in African Americans (AA) (f = 37%) and rare in European Americans (f < 3%) or Europeans (f = 5%). For AA, the variant allele 186R was strongly associated with decline in CD4 T cells (CD4 slope on square root scale: −1.86, P = 0.009), The 186R allele was also associated with accelerated progression to AIDS-defining conditions in AA. The in vitro antiviral activity of the 186R enzyme was not inferior to that of the common H186 variant. These studies suggest that there may be a modifying role of variants of APOBEC3G on HIV-1 disease progression that warrants further investigation.
Language
  • English
Open access status
bronze
Identifiers
Persistent URL
https://sonar.ch/global/documents/182480
Statistics

Document views: 22 File downloads:
  • fulltext.pdf: 0